Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Folliculitis decalvans mainly affects middle-aged African American men and is treated with antibiotics.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

Ayurvedic treatment may help manage alopecia areata.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.